En los estudios AWARD, el tratamiento con dulaglutida a dosis de 1,50mg semanal se asoci a una perdida ponderal promedio entre 0,70-2,90kg (0,70-3,00%)24,43, la prdida de peso se mantuvo de forma consistente durante 104 semanas de seguimiento en el estudio AWARD-544
Patient safety issues in the GLP-1 space this week An article in the San Francisco Standard examined a San Francisco Bay Area trend of tech industry professionals injecting research-grade peptides, including GLP-1s, hoping for boosts in health or performance
The role of M6a rna methylation in cancer metabolism
Researchers found that GLP-1 signaling directly correlated with the decrease of pro-inflammatory cytokine production, which includes tumor necrosis factor-alpha (TNF-) and interleukin-6 (IL-6)
Individuals dealing with conditions like neuropathy may find much-needed relief after regular injections